Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …

In December 2019, a new type of coronavirus was detected for the first time in Wuhan, Hubei
Province, China. According to the reported data, the emerging coronavirus has spread …

Preventing communicable diseases requires understanding the spread, epidemiology,
clinical features, progression, and prognosis of the disease. Early identification of risk factors …

Despite the growing knowledge of the clinicopathological features of COVID-19, the
correlation between early changes in the laboratory parameters and the clinical outcomes of …

Materials and methods The study included all the admitted patients (n= 100) having COVID-
19 polymerase chain reaction (PCR) positive, and evaluated clinical profiles and …

Severe pulmonary disease caused by the novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2)], has devastated many countries around the world. It …

The length of stay in the hospital for COVID-19 can aid in understanding the disease's
prognosis. Thus, the goal of this study was to collectively estimate the hospital length of stay …

The mortality rates of COVID-19 vary across the globe. While some risk factors for poor
prognosis of the disease are known, regional differences are suspected. We reviewed the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic
and causes severe symptoms; in addition to respiratory syndromes, patients might …

At the end of 2019, the entire world has witnessed the birth of a new member of coronavirus
family in Wuhan, China. Ever since, the Severe Acute Respiratory Syndrome Coronavirus 2 …